RT Journal Article SR Electronic T1 Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 871 OP 877 DO 10.2967/jnumed.116.182873 VO 58 IS 6 A1 Eric A. Osborn A1 Chase W. Kessinger A1 Ahmed Tawakol A1 Farouc A. Jaffer YR 2017 UL http://jnm.snmjournals.org/content/58/6/871.abstract AB Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, 18F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment.